Trial Profile
Retrospective study of low dose and less frequent administration of rosuvastatin in rosuvastatin intolerant patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2015
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Dyslipidaemias
- Focus Adverse reactions; Therapeutic Use
- 28 Nov 2015 New trial record